{"id":"https://openalex.org/W3190201848","doi":"https://doi.org/10.31083/j.ejgo4204117","title":"The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer","display_name":"The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3190201848","doi":"https://doi.org/10.31083/j.ejgo4204117","mag":"3190201848"},"language":"en","primary_location":{"id":"doi:10.31083/j.ejgo4204117","doi":"https://doi.org/10.31083/j.ejgo4204117","is_oa":true,"landing_page_url":"https://doi.org/10.31083/j.ejgo4204117","pdf_url":null,"source":{"id":"https://openalex.org/S185000910","display_name":"European Journal of Gynaecological Oncology","issn_l":"0392-2936","issn":["0392-2936","2709-0086"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310322753","host_organization_name":"IMR Press","host_organization_lineage":["https://openalex.org/P4310322753"],"host_organization_lineage_names":["IMR Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Gynaecological Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3190201848"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.31083/j.ejgo4204117","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5127090995","display_name":"CANDAN DEM\u0130R\u00d6Z ABAKAY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DEM\u0130R\u00d6Z ABAKAY, CANDAN","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028025879","display_name":"Adem Delig\u00f6n\u00fcl","orcid":"https://orcid.org/0000-0002-3669-6391","observed_orcids":["https://orcid.org/0000-0002-3669-6391","https://orcid.org/0009-0001-3931-0191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DEL\u0130G\u00d6N\u00dcL, ADEM","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073348062","display_name":"K Ozerkan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00d6ZERKAN, KEMAL","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019684103","display_name":"Mine \u00d6z\u015fen","orcid":"https://orcid.org/0000-0002-5771-7649","observed_orcids":["https://orcid.org/0000-0002-5771-7649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00d6Z\u015eEN, M\u0130NE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125015541","display_name":"Fatma \u00d6z Atalay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00d6Z ATALAY, FATMA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005217743","display_name":"Ahmet Bilgehan \u015eahin","orcid":"https://orcid.org/0000-0002-7846-0870","observed_orcids":["https://orcid.org/0000-0002-7846-0870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u015eAH\u0130N, AHMET B\u0130LGEHAN","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002297877","display_name":"Hakan Ozan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"OZAN, HAKAN","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008425506","display_name":"Ulviyya Hasanzade","orcid":"https://orcid.org/0000-0001-7546-2865","observed_orcids":["https://orcid.org/0000-0001-7546-2865"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HASANZADE, ULVIYYA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027237391","display_name":"Birol Ocak","orcid":"https://orcid.org/0000-0001-7537-1699","observed_orcids":["https://orcid.org/0000-0001-7537-1699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"OCAK, B\u0130ROL","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078219900","display_name":"E Cubukcu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c7UBUK\u00c7U, ERDEM","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141775967","display_name":"Turkkan Evrense","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evrense, Turkkan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5141596332","display_name":"Merve Mesahorli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mesahorli, Merve","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2099,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.48244443,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"42","issue":"4","first_page":"775","last_page":"775"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.6029999852180481,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.6029999852180481,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.39430001378059387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/low-risk-endometrial-cancer","display_name":"low-risk endometrial cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ki-67-proliferation-index","display_name":"Ki-67 proliferation index","score":0.996999979019165},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.875},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.8939999938011169},{"id":"https://openalex.org/keywords/platelet-to-lymphocyte-ratio","display_name":"platelet-to-lymphocyte ratio","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lymphocyte-to-monocyte-ratio","display_name":"lymphocyte-to-monocyte ratio","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.5299999713897705},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9390792846679688},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.7612541913986206},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.7499038577079773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5718088746070862},{"id":"https://openalex.org/C198677920","wikidata":"https://www.wikidata.org/wiki/Q3299937","display_name":"Neutrophile","level":3,"score":0.566495418548584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4937172830104828},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.49075254797935486},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4621726870536804},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42592093348503113},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40335315465927124},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.23165598511695862}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.31083/j.ejgo4204117","doi":"https://doi.org/10.31083/j.ejgo4204117","is_oa":true,"landing_page_url":"https://doi.org/10.31083/j.ejgo4204117","pdf_url":null,"source":{"id":"https://openalex.org/S185000910","display_name":"European Journal of Gynaecological Oncology","issn_l":"0392-2936","issn":["0392-2936","2709-0086"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310322753","host_organization_name":"IMR Press","host_organization_lineage":["https://openalex.org/P4310322753"],"host_organization_lineage_names":["IMR Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Gynaecological Oncology","raw_type":"journal-article"},{"id":"pmh:aec930c8-45ba-45a5-a8cd-b3dfa79217cf","doi":null,"is_oa":false,"landing_page_url":"https://avesis.uludag.edu.tr/publication/details/aec930c8-45ba-45a5-a8cd-b3dfa79217cf/oai","pdf_url":null,"source":{"id":"https://openalex.org/S7407055210","display_name":"Bursa Uludag University - AVESIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.31083/j.ejgo4204117","doi":"https://doi.org/10.31083/j.ejgo4204117","is_oa":true,"landing_page_url":"https://doi.org/10.31083/j.ejgo4204117","pdf_url":null,"source":{"id":"https://openalex.org/S185000910","display_name":"European Journal of Gynaecological Oncology","issn_l":"0392-2936","issn":["0392-2936","2709-0086"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310322753","host_organization_name":"IMR Press","host_organization_lineage":["https://openalex.org/P4310322753"],"host_organization_lineage_names":["IMR Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Gynaecological Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388345255","https://openalex.org/W2940226797","https://openalex.org/W4414184509","https://openalex.org/W3026767499","https://openalex.org/W4312139778","https://openalex.org/W3211995450","https://openalex.org/W1873561454","https://openalex.org/W4379335632","https://openalex.org/W4280621511","https://openalex.org/W1833610523"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"investigate":[2],"the":[3,19,40,85,95,116,125,129,133,154,191,215,220],"prognostic":[4,216],"factors":[5,199],"comparing":[6],"clinical,":[7],"histopathological,":[8],"and":[9,32,35,63,89,104,115,138,146,163,180,194,205,223],"laboratory":[10,33],"parameters":[11],"in":[12,100,225],"low-risk":[13,46,226],"endometrial":[14],"cancer":[15],"(EC).":[16],"Methods:":[17],"In":[18,91],"present":[20,212],"single-center":[21],"study,":[22],"multivariate":[23,187],"Cox":[24],"regression":[25],"analysis":[26,69,188],"was":[27,70,79,98,110,120],"performed":[28,99],"on":[29],"retrospective":[30],"clinical":[31],"data":[34],"histopathological":[36],"features":[37],"obtained":[38],"from":[39],"re-evaluation":[41],"of":[42,84,94,218],"253":[43],"patients":[44,86,155],"with":[45,156],"EC.":[47,227],"Receiver":[48],"operating":[49],"characteristic":[50],"curves":[51],"(ROC)":[52],"were":[53,87,140,196],"plotted":[54],"for":[55,66,72,132,177,184,200],"neutrophile-lymphocyte":[56],"ratio":[57,62],"(NLR),":[58],"platelet-lymphocyte":[59],"ratio,":[60],"lymphocyte-monocyte":[61],"Ki-67":[64,118,134,158,178,192,221],"index":[65,119,159,179,193,222],"recurrence.":[67],"Kaplan-Meier":[68],"employed":[71],"survival":[73,172],"rates.":[74],"Results:":[75],"The":[76,106,149,186,211],"median":[77,107,117],"age":[78],"58.5":[80],"years":[81],"(32.0\u201375.4).":[82],"Most":[83],"obese":[88],"post-menopausal.":[90],"nearly":[92],"half":[93],"patients,":[96],"lymphadenectomy":[97],"addition":[101],"to":[102,124],"hysterectomy":[103],"oophorectomy.":[105],"tumor":[108],"size":[109],"30":[111],"mm":[112],"(range":[113],"2\u201380),":[114],"25":[121],"(1\u201390).":[122],"According":[123],"ROC":[126],"curve":[127],"analysis,":[128],"cut-off":[130],"values":[131],"index,":[135],"NLR,":[136],"PLR,":[137],"LMR":[139],"determined":[141],"as":[142],"\u226522,":[143],"\u22651.98,":[144],"\u2265115.3,":[145],"\u22644.71,":[147],"respectively.":[148],"log-rank":[150],"test":[151],"revealed":[152,189],"that":[153,190],"a":[157],"lower":[160,165],"than":[161,166],"22%":[162],"NLR":[164,195,224],"1.98":[167],"had":[168],"statistically":[169,197],"longer":[170],"recurrence-free":[171],"(RFS)":[173],"(p":[174,202],"=":[175,182,203,207],"0.002":[176],"p":[181,206],"0.004":[183],"NLR).":[185],"significant":[198],"RFS":[201],"0.012":[204],"0.029,":[208],"respectively).":[209],"Conclusion:":[210],"study":[213],"highlights":[214],"implications":[217],"both":[219]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-08-16T00:00:00"}